New-onset diabetes after transplantation
- PMID: 15093805
- DOI: 10.1016/j.healun.2004.03.007
New-onset diabetes after transplantation
Abstract
For many years new-onset diabetes after transplantation has been recognized as a complication of solid-organ transplantation, although its importance has been greatly underestimated. Studies have shown that the cumulative incidence of this condition in heart transplant recipients may reach 32% at 5 years, similar to that reported in kidney and liver transplant patients. Several factors predispose to increased risk for developing new-onset diabetes after transplantation, including age, ethnicity, family history of diabetes, obesity and immunosuppressive therapy. Corticosteroids are associated with the greatest risk of developing the condition. Tacrolimus is more diabetogenic than cyclosporine in kidney and liver transplant patients, but there are few data reporting the effects of these agents in heart transplant patients. In kidney transplant patients, diabetes is known to be a significant risk factor for cardiovascular disease post-transplant. Although this has yet to be demonstrated clearly in heart transplant patients, evidence suggests that new-onset diabetes after transplantation may play a role in the development of cardiac allograft vasculopathy (CAV). Because CAV is the major limitation to long-term survival in this population, it is clear that efforts should be made to reduce the risk of diabetes and treat this condition appropriately. Management of transplant recipients with new-onset diabetes after transplantation has been assisted by the recent publication of International Consensus Guidelines. The guidelines were developed to establish a standard definition and describe risk factors for new-onset diabetes after transplantation. Use of these guidelines will help to prospectively identify those at risk of developing new-onset diabetes after transplantation so that therapeutic strategies can be individualized early in the treatment regimen. These management approaches should help to lower the risk of new-onset diabetes after heart transplantation and reduce the possible long-term consequences of the condition.
Similar articles
-
Guidelines for the treatment and management of new-onset diabetes after transplantation.Clin Transplant. 2005 Jun;19(3):291-8. doi: 10.1111/j.1399-0012.2005.00359.x. Clin Transplant. 2005. PMID: 15877787 Review.
-
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.J Heart Lung Transplant. 2004 May;23(5 Suppl):S187-93. doi: 10.1016/j.healun.2004.03.009. J Heart Lung Transplant. 2004. PMID: 15093804 Review.
-
New-onset diabetes mellitus after solid organ transplantation.Transpl Int. 2009 May;22(5):519-30. doi: 10.1111/j.1432-2277.2008.00800.x. Epub 2008 Nov 20. Transpl Int. 2009. PMID: 19040489 Review.
-
New-onset cardiovascular risk factors in lung transplant recipients.J Heart Lung Transplant. 2005 Oct;24(10):1536-43. doi: 10.1016/j.healun.2005.01.004. J Heart Lung Transplant. 2005. PMID: 16210127
-
[Post-transplantation diabetes mellitus].Nephrol Ther. 2006 Jan;2 Suppl 1:S71-6. Nephrol Ther. 2006. PMID: 17378145 Review. French.
Cited by
-
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant.Biomedicines. 2022 Oct 26;10(11):2704. doi: 10.3390/biomedicines10112704. Biomedicines. 2022. PMID: 36359224 Free PMC article.
-
1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease.ERJ Open Res. 2021 Aug 23;7(3):00103-2021. doi: 10.1183/23120541.00103-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34435032 Free PMC article.
-
Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review.J Transplant. 2018 Jan 29;2018:1025893. doi: 10.1155/2018/1025893. eCollection 2018. J Transplant. 2018. PMID: 29623219 Free PMC article. Review.
-
Impact of Insurance Type on Initial Rejection Post Heart Transplant.Heart Lung Circ. 2017 Feb;26(2):164-171. doi: 10.1016/j.hlc.2016.05.123. Epub 2016 Jul 18. Heart Lung Circ. 2017. PMID: 27475258 Free PMC article. Clinical Trial.
-
Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.PLoS One. 2015 Nov 9;10(11):e0142363. doi: 10.1371/journal.pone.0142363. eCollection 2015. PLoS One. 2015. PMID: 26551468 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical